stoxline Quote Chart Rank Option Currency Glossary
  
(VISN)
  0 (0%)    03-29 11:51
Open:
High:
Volume: 0
  
Pre. Close:
Low:
Market Cap: 0(M)
Technical analysis
2024-03-28 4:55:01 PM
Short term     
Mid term     
Targets 6-month :  285.72 1-year :  333.73
Resists First :  244.63 Second :  285.72
Pivot price 238.92
Supports First :  236.07 Second :  230.78
MAs MA(5) :  242.22 MA(20) :  237.97
MA(100) :  219.55 MA(250) :  206.09
MACD MACD :  3.7 Signal :  3.5
%K %D K(14,3) :  86.5 D(3) :  78.6
RSI RSI(14): 70.9
52-week High :  244.63 Low :  182.58
Price, MAs and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ VIS ] has closed below upper band by 11.2%. Bollinger Bands are 8% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction
If tomorrow: Open lower Open higher
High: 245.32 - 246.68 246.68 - 247.79
Low: 239.34 - 241.31 241.31 - 242.91
Close: 241.27 - 244.17 244.17 - 246.54
Company Description

Gyroscope Therapeutics Holdings plc, a clinical-stage gene therapy company, through its subsidiaries, develops gene therapy products to treat patients with eye diseases. It focuses on developing a pipeline of recombinant adeno-associated virus vector-based gene therapy candidates targeting genetic variants in the complement pathway for age-related macular degeneration. The company is developing GT005, which is in Phase II clinical trials for the treatment of geographic atrophy secondary to age-related macular degeneration; and GT011, a preclinical recombinant adeno-associated virus gene therapy, for the treatment of geographic atrophy secondary to age-related macular degeneration. The company was founded in 2016 and is headquartered in Stevenage, the United Kingdom.

Headline News

Tue, 26 Mar 2024
Jennifer Kryskalla Marin - Veterans Affairs

Thu, 14 Mar 2024
VA LETC and VISN 8 Graduates 38 New VA Police Officers - Veterans Affairs

Wed, 13 Mar 2024
CVAHCS’s Medical Surgery Inpatient unit named Top Huddle Board for VISN-7 - Veterans Affairs

Tue, 12 Mar 2024
About Us - Veterans Affairs

Tue, 20 Feb 2024
VISN 7 CMO retires after 33 years of service - Veterans Affairs

Thu, 18 Jan 2024
VISN 8 Staff Defer to Expertise on Journey Toward High Reliability - Veterans Affairs

Financial Analysis
Price to Book Value:
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Neutral
Price to Earnings:
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Neutral
Discounted cash flow:
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Neutral
Return on Assets:
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Neutral
Return on Equity:
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Neutral
Debt to Equity:
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Neutral
Stock Basics & Statistics
Exchange:
Sector:
Healthcare
Industry:
Advertising Agencies
Shares Out 0 (M)
Shares Float 0 (M)
Held by Insiders 0 (%)
Held by Institutions 0 (%)
Shares Short 0 (K)
Shares Short P.Month 0 (K)
Stock Financials
EPS 0
EPS Est Next Qtrly 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) 0
Profit Margin 0 %
Operating Margin 0 %
Return on Assets (ttm) 0 %
Return on Equity (ttm) 0 %
Qtrly Rev. Growth 0 %
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0 %
Operating Cash Flow 0 (M)
Levered Free Cash Flow 0 (M)
Stock Valuations
PE Ratio 0
PEG Ratio 0
Price to Book value 0
Price to Sales 0
Price to Cash Flow 0
Stock Dividends
Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.

StockChart iOS

StoxlineLite iOS

StoxlineLite iOS

OptionCalc iOS

StockChart Android

StoxlineLite Android

StoxlinePro Android

OptionCalc Android